ADVERTISEMENT

If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.

It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.

Wiley InterScience

Nephrology

Nephrology

Volume 11 Issue 2, Pages 147 - 150

Published Online: 13 Apr 2006

Journal Compilation © 2009 Asian Pacific Society of Nephrology



< Previous Abstract  |  Next Abstract >

Save Article to My Profile      Download Citation      Request Permissions

Abstract |  References  |  Full Text: HTML, PDF (Size: 121K)  | Related Articles | Citation Tracking

Colchicine myoneuropathy in chronic renal failure patients with gout (Case Report)
I-CHUN LAI 1 , CHUNG-YI CHENG 1 , HSI-HSIEN CHEN 1 , WEI-YU CHEN 2 and PEI-YUAN CHEN 1
  1 Department of Nephrology, Taipei Medical University Hospital and   2 Department of Pathology, Wang-Fang Hospital, Taipei, Taiwan
Correspondence to  Dr Pei-Yuan Chen, Department of Nephrology, Taipei Medical University Hospital, 252, Wu-Hsing Street, Taipei, 10502, Taiwan.
Email:pychen@tmu.edu.tw
Copyright 2006 Asian Pacific Society of Nephrology
KEYWORDS
chronic renal failure • colchicine myoneuropathy • gout

ABSTRACT

SUMMARY:  Colchicine myoneuropathy is a rare and often underdiagnosed disease. It often presents as painless subacute muscle weakness. We present a case of painful colchicine myoneuropathy in a 76-year-old man with chronic renal failure and gout. Published work about clinical presentations of colchicine myoneuropathy in gouty arthritis patients are reviewed. During the previous year, the patient had a drug regimen of colchicine 0.5 mg three times per day for a 3 day course each month. He developed bilateral lower leg weakness and severe myalgia. His serum creatinine level was 680.7 µmol/L and creatinine kinase was 959 IU/L on admission. Laboratory findings included decreasing amplitude of motor and sensory nerve conduction velocity and an electromyogram showed small amplitude, short duration polyphasic waves over the right biceps. A muscle biopsy disclosed vacuolar changes in the cytoplasm. These results all supported a diagnosis of colchicine myoneuropathy. After cessation of colchicine, the creatinine kinase level decreased approximately 50% in 6 days, myalgia subsided and his muscle weakness improved gradually over the next 2 weeks.


Accepted for publication 31 October 2005.

DIGITAL OBJECT IDENTIFIER (DOI)
10.1111/j.1440-1797.2006.00542.x About DOI

Related Articles

  • Find other articles like this in Wiley InterScience
  • Find articles in Wiley InterScience written by any of the authors

Wiley InterScience is a member of CrossRef.

Cross Ref Member


Latest News & Information
Special Issue, ANCA Associated Vasculitis
Sign Up Now
Sign Up Now